Minimal residual disease: what are the minimum requirements?

J Clin Oncol. 2014 Feb 10;32(5):475-6. doi: 10.1200/JCO.2013.52.1955. Epub 2014 Jan 13.

Authors

Mark Roschewski¹, Maryalice Stetler-Stevenson, Constance Yuan, Sham Mailankody, Neha Korde, Ola Landgren

Affiliation

¹ Center for Cancer Research, National Institutes of Health, Bethesda, MD.

PMID: 24419126
DOI: 10.1200/JCO.2013.52.1955

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Female
Hematopoietic Stem Cell Transplantation / methods*
Humans
Male
Multiple Myeloma / drug therapy*
Neoplasm, Residual / drug therapy*
Neoplasm, Residual / pathology*